Skip to content

Homoeopathic treatment of lumbar spondylosis

Efficacy of individualized homoeopathic medicines in Q-potency in treatment of lumbar spondylosis: a double-blind, randomized, placebo-controlled, clinical trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043506
Enrollment
60
Registered
2022-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Individualized Homoeopathic medicines in Q-(50 millesimal ) potency: Intervention is planned as administering indicated homoeopathic medicines in Q-(50 millesimal ) potency, as decided

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with radiological diagnosis of lumbar spondylosis (2022 ICD-10-CM Diagnosis Code M47.816) Spondylosis w/o myelopathy or radiculopathy, lumbar region 2. Patients who have not taken any treatment since at least 2 weeks for lumbar spondylosis. 3. Literate patients; can read Bengali and/or English 4. Providing written informed consent to participate in the trial

Exclusion criteria

Exclusion criteria: 1. Patients suffering from severe degenerative changes as found in radiological findings of lumbar spondylosis. 2. Patients having major life threatening disorder associated with lumbar spondylosis 3. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life. 4. Patients who are too sick for consultation. 5. Pregnant and puerperal women, and lactating mothers. 6. Substance abuse and/or dependence 7. Self-reported immune-compromised state 8. Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Visual analog scale (VAS) for pain.Timepoint: At baseline, after 3 months and 6 months

Secondary

MeasureTime frame
oswestry disability indexTimepoint: At baseline, after 3 months and 6 months

Countries

India

Contacts

Public ContactHIMANGSU HAIT

The Calcutta Homoeopathic Medical College and Hospital

haitdrhimangsu@gmail.com9433565680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026